Home/Pipeline/LV232

LV232

Depression

Phase 2Active

Key Facts

Indication

Depression

Phase

Phase 2

Status

Active

Company

About Vigonvita

A Chinese biopharma company with a fully integrated platform developing and commercializing drugs for viral infections, neuropsychiatry, and reproductive health.

View full company profile

Therapeutic Areas

Infectious Disease Neurology Psychiatry Urology/Reproductive Health

Other Depression Drugs

Drug	Company	Phase	Status
Undisclosed Programs	Johnson and Johnson Innovative Medicine	Pipeline	Active
Depression Clinical Trials	IMA Clinical Research	Not Applicable (Service)	Active
Depression Study	Sun Valley Research Center	Not Disclosed	Active
eTNS Platform	NeuroSigma	Unknown	Active
ALM003	Almatica Pharma	Phase 3	Active
ALM014	Almatica Pharma	Pivotal BA/BE	Active
NRCT-101SR	Neurocentria	Phase 2b/3	Active
Starstim for Depression	Neuroelectrics	Phase 1/2	Active
Depression Biomarkers	Paradise Genomics	Discovery	Active
Home-tDCS Depression Trial	Soterix Medical	N/A (Device-enabled trial)	Active
BPL-003	AtaiBeckley	Phase 2	Active
VLS-01	AtaiBeckley	Phase 2	Active